文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

V 结构域免疫球蛋白抑制 T 细胞活化蛋白的结构和功能结合表位

Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.

机构信息

Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.

Stanford Synchrotron Radiation Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA.

出版信息

Cell Rep. 2019 Sep 3;28(10):2509-2516.e5. doi: 10.1016/j.celrep.2019.07.073.


DOI:10.1016/j.celrep.2019.07.073
PMID:31484064
Abstract

V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA) is an immune checkpoint protein that inhibits the T cell response against cancer. Similar to PD-1 and CTLA-4, a blockade of VISTA promotes tumor clearance by the immune system. Here, we report a 1.85 Å crystal structure of the elusive human VISTA extracellular domain, whose lack of homology necessitated a combinatorial MR-Rosetta approach for structure determination. We highlight features that make the VISTA immunoglobulin variable (IgV)-like fold unique among B7 family members, including two additional disulfide bonds and an extended loop region with an attached helix that we show forms a contiguous binding epitope for a clinically relevant anti-VISTA antibody. We propose an overlap of this antibody-binding region with the binding epitope for V-set and Ig domain containing 3 (VSIG3), a purported functional binding partner of VISTA. The structure and functional epitope presented here will help guide future drug development efforts against this important checkpoint target.

摘要

V 结构域免疫球蛋白(Ig)抑制 T 细胞活化(VISTA)是一种免疫检查点蛋白,可抑制针对癌症的 T 细胞反应。与 PD-1 和 CTLA-4 类似,VISTA 的阻断可促进免疫系统清除肿瘤。在这里,我们报告了难以捉摸的人类 VISTA 细胞外结构域的 1.85Å 晶体结构,由于缺乏同源性,因此需要采用组合的 MR-Rosetta 方法来确定结构。我们强调了使 VISTA 的免疫球蛋白可变(IgV)样折叠在 B7 家族成员中独一无二的特征,包括两个额外的二硫键和一个带有附加螺旋的扩展环区,我们证明该环区形成了与临床相关的抗 VISTA 抗体的连续结合表位。我们提出该抗体结合区域与 V 集和 Ig 域包含 3(VSIG3)的结合表位重叠,VSIG3 是 VISTA 的假定功能结合伙伴。此处呈现的结构和功能表位将有助于指导针对该重要检查点靶标的未来药物开发工作。

相似文献

[1]
Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.

Cell Rep. 2019-9-3

[2]
Structural Basis of VSIG3: The Ligand for VISTA.

Front Immunol. 2021

[3]
An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.

Sci Rep. 2020-9-16

[4]
Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.

Oral Oncol. 2016-6

[5]
The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma.

Cancer Immunol Immunother. 2024-6-4

[6]
VISTA is an immune checkpoint molecule for human T cells.

Cancer Res. 2014-4-1

[7]
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors.

J Med Chem. 2024-3-14

[8]
VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.

Trends Immunol. 2021-3

[9]
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.

Front Immunol. 2021

[10]
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.

Front Immunol. 2020

引用本文的文献

[1]
A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.

Cancer Res. 2025-7-14

[2]
Negative Immune Checkpoint Inhibitors.

Pharmaceutics. 2025-5-28

[3]
[IGSF11: A Novel Target for Cancer Immunotherapy].

Zhongguo Fei Ai Za Zhi. 2025-5-20

[4]
Emerging new immune checkpoint inhibitors in solid tumor immunotherapy.

Naunyn Schmiedebergs Arch Pharmacol. 2025-4-11

[5]
YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer.

Cell Death Differ. 2025-5

[6]
VISTA-induced tumor suppression by a four amino acid intracellular motif.

bioRxiv. 2025-1-5

[7]
FOXO1 pathway activation by VISTA immune checkpoint restrains pulmonary ILC2 functions.

J Clin Invest. 2025-1-2

[8]
VISTA in hematological malignancies: a review of the literature.

Front Immunol. 2024-12-17

[9]
Mapping the Binding Hotspots and Transient Binding Pockets on V-Domain Immunoglobulin Suppressor of T Cell Activation Protein Surface.

ACS Omega. 2024-11-23

[10]
A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy.

Biomark Res. 2024-12-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索